Ana C. Alho

558 total citations
12 papers, 404 citations indexed

About

Ana C. Alho is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Ana C. Alho has authored 12 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 9 papers in Immunology and 3 papers in Oncology. Recurrent topics in Ana C. Alho's work include Hematopoietic Stem Cell Transplantation (9 papers), T-cell and B-cell Immunology (8 papers) and Immune Cell Function and Interaction (8 papers). Ana C. Alho is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), T-cell and B-cell Immunology (8 papers) and Immune Cell Function and Interaction (8 papers). Ana C. Alho collaborates with scholars based in Portugal, United States and France. Ana C. Alho's co-authors include Jerome Ritz, Vincent T. Ho, Robert J. Soiffer, Edwin P. Alyea, Joseph H. Antin, John Koreth, Corey Cutler, Haesook T. Kim, Sarah Nikiforow and Philippe Armand and has published in prestigious journals such as Blood, Frontiers in Immunology and JCI Insight.

In The Last Decade

Ana C. Alho

12 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana C. Alho Portugal 8 314 218 85 43 31 12 404
Qingxiao Song China 8 222 0.7× 152 0.7× 96 1.1× 36 0.8× 25 0.8× 26 310
Marie J Chammas United States 3 213 0.7× 186 0.9× 57 0.7× 29 0.7× 24 0.8× 6 289
Cristina Toffalori Italy 7 276 0.9× 301 1.4× 95 1.1× 29 0.7× 17 0.5× 20 387
Arwen Stikvoort Sweden 12 264 0.8× 131 0.6× 189 2.2× 61 1.4× 17 0.5× 25 389
SA Brown United States 3 188 0.6× 344 1.6× 58 0.7× 56 1.3× 59 1.9× 5 432
Stephan Schulz United States 2 293 0.9× 165 0.8× 60 0.7× 44 1.0× 29 0.9× 2 404
M Sykes United States 6 316 1.0× 275 1.3× 71 0.8× 62 1.4× 44 1.4× 9 459
Brigitte Bär Netherlands 12 157 0.5× 379 1.7× 95 1.1× 40 0.9× 57 1.8× 16 438
Jane Nunnick United Kingdom 8 208 0.7× 372 1.7× 89 1.0× 90 2.1× 34 1.1× 16 471
Natalie Schub Germany 8 88 0.3× 164 0.8× 143 1.7× 56 1.3× 28 0.9× 21 292

Countries citing papers authored by Ana C. Alho

Since Specialization
Citations

This map shows the geographic impact of Ana C. Alho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana C. Alho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana C. Alho more than expected).

Fields of papers citing papers by Ana C. Alho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana C. Alho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana C. Alho. The network helps show where Ana C. Alho may publish in the future.

Co-authorship network of co-authors of Ana C. Alho

This figure shows the co-authorship network connecting the top 25 collaborators of Ana C. Alho. A scholar is included among the top collaborators of Ana C. Alho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana C. Alho. Ana C. Alho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Doglio, Matteo, Rachel E. Crossland, Ana C. Alho, et al.. (2022). Cell-based therapy in prophylaxis and treatment of chronic graft-versus-host disease. Frontiers in Immunology. 13. 1045168–1045168. 9 indexed citations
2.
Whangbo, Jennifer, Sarah Nikiforow, Haesook T. Kim, et al.. (2022). A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease. Blood Advances. 6(21). 5786–5796. 23 indexed citations
3.
Matos, Tiago R., et al.. (2021). Maturation and Phenotypic Heterogeneity of Human CD4+ Regulatory T Cells From Birth to Adulthood and After Allogeneic Stem Cell Transplantation. Frontiers in Immunology. 11. 570550–570550. 11 indexed citations
4.
Soares, Maria V. D., Rita I Azevedo, Ana Vieira, et al.. (2019). Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease. Frontiers in Immunology. 10. 334–334. 17 indexed citations
5.
6.
Whangbo, Jennifer, Haesook T. Kim, Sarah Nikiforow, et al.. (2019). Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease. Blood Advances. 3(7). 984–994. 24 indexed citations
7.
Hirakawa, Masahiro, Tiago R. Matos, Hongye Liu, et al.. (2016). Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells. JCI Insight. 1(18). e89278–e89278. 106 indexed citations
8.
Forcade, Édouard, Haesook T. Kim, Corey Cutler, et al.. (2016). Circulating T follicular helper cells with increased function during chronic graft-versus-host disease. Blood. 127(20). 2489–2497. 85 indexed citations
9.
10.
Alho, Ana C., Haesook T. Kim, Marie J Chammas, et al.. (2015). Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD. Blood. 127(5). 646–657. 123 indexed citations
11.
Alho, Ana C., Carol Reynolds, Marie J Chammas, et al.. (2014). Homeostatic Reconstitution of CD4+ Regulatory and Conventional T Cell Subsets in Adult Patients after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT). Blood. 124(21). 2496–2496. 1 indexed citations
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qingxiao Song Breakdown of academic impact, for papers by Marie J Chammas Breakdown of academic impact, for papers by Cristina Toffalori Breakdown of academic impact, for papers by Arwen Stikvoort Breakdown of academic impact, for papers by SA Brown Breakdown of academic impact, for papers by Stephan Schulz Breakdown of academic impact, for papers by M Sykes Breakdown of academic impact, for papers by Brigitte Bär Breakdown of academic impact, for papers by Jane Nunnick Breakdown of academic impact, for papers by Natalie Schub
Rankless by CCL
2026